Fri, November 30, 2018
Thu, November 29, 2018
Wed, November 28, 2018
Tue, November 27, 2018
Mon, November 26, 2018
Fri, November 23, 2018
Wed, November 21, 2018
Tue, November 20, 2018

Paul Matteis Initiated (ALNY) at Hold and Held Target at $63 on, Nov 28th, 2018

Paul Matteis of Leerink Swann, Initiated "Alnylam Pharmaceuticals, Inc." (ALNY) at Hold and Held Target at $63 on, Nov 28th, 2018.

Paul has made no other calls on ALNY in the last 4 months.



There are 7 other peers that have a rating on ALNY. Out of the 7 peers that are also analyzing ALNY, 1 agrees with Paul's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $87 on, Friday, September 28th, 2018


These are the ratings of the 6 analyists that currently disagree with Paul


  • Do Kim of "BMO Capital" Maintained at Buy with Decreased Target to $124 on, Tuesday, October 16th, 2018
  • Olivia Brayer of "Cantor Fitzgerald" Initiated at Buy and Held Target at $135 on, Monday, October 1st, 2018
  • Christopher Marai of "Nomura" Maintained at Sell with Decreased Target to $73 on, Monday, August 13th, 2018
  • Madhu Kumar of "B. Riley Securities" Maintained at Strong Buy with Increased Target to $230 on, Monday, August 13th, 2018
  • Ritu Baral of "Cowen & Co." Maintained at Buy with Decreased Target to $147 on, Monday, August 13th, 2018
  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $123 on, Monday, August 13th, 2018